Co-Diagnostics, Inc. (CODX) has 20 open-market insider trades by 7 insiders since 2018. The most active filer is Brent Satterfield, Chief Science Officer & 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Brent Satterfield | Chief Science Officer10% | — | 6 | $11.8M | 2018-05-11 |
| Dwight H. Egan | CEO | — | 2 | $3.3M | 2026-05-23 |
| Reed L. Benson | CLO | — | 2 | $2.8M | 2021-05-24 |
| Eugene Durenard | Dir | — | 5 | $2.5M | 2026-05-23 |
| Richard S. Serbin | Dir | — | 3 | $1.3M | 2026-05-23 |
| James B. Nelson | Dir | — | 1 | $247K | 2026-05-23 |
| Brian Lee Brown | CFO | — | 1 | $6K | 2026-05-23 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Brian Lee Brown | CFO | Buy | $6K | 2023-03-20 |
| Eugene Durenard | Director | Sell | $21K | 2021-09-08 |
| Reed L. Benson | CLO | Sell | $1.8M | 2021-05-19 |
| Dwight H. Egan | CEO | Sell | $419K | 2021-01-15 |
| Richard S. Serbin | Director | Sell | $206K | 2021-01-14 |
| Eugene Durenard | Director | Sell | $106K | 2021-01-13 |
Companies that share insiders with CODX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| James B. Nelson | Director | Sell | $247K | 2021-01-13 |
| Richard S. Serbin | Director | Sell | $172K | 2020-12-14 |
| Eugene Durenard | Director | Sell | $102K | 2020-12-10 |
| Reed L. Benson | CFO & Secretary | Sell | $940K | 2020-11-25 |
| Dwight H. Egan | CEO | Sell | $2.8M | 2020-11-20 |
| Eugene Durenard | Director | Sell | $917K | 2020-05-20 |
| Eugene Durenard | Director | Sell | $1.4M | 2020-05-20 |
| Richard S. Serbin | Director | Sell | $913K | 2020-05-19 |
| Brent Satterfield | Chief Science Officer & 10% | Buy | $2K | 2018-05-11 |